Comparative Selectivity and Specificity of the Proteasome Inhibitors BzLLLCOCHO, PS-341, and MG-132

作者: Lisa J.A. Crawford , Brian Walker , Huib Ovaa , Dharminder Chauhan , Kenneth C. Anderson

DOI: 10.1158/0008-5472.CAN-06-0605

关键词: OligopeptideProteaseCell cultureProteasome inhibitorBortezomibCytotoxicityBiochemistryProtein subunitBiologyProteasomeCancer researchOncology

摘要: The 26S proteasome is a multicatalytic protease responsible for regulated intracellular protein degradation. Its function mediated by three main catalytic activities: (a) chymotrypsin-like (CT-L), (b) trypsin-like, and (c) peptidylglutamyl peptide hydrolysing (PGPH). Proteasome inhibition an emerging therapy many cancers novel treatment multiple myeloma. Here, we profile the contributions of activities in myeloma cell lines compare specificity cytotoxicity inhibitor BzLLLCOCHO inhibitors PS-341 (Velcade, bortezomib) MG-132. Using fluorogenic substrates active site-directed probe specific subunits, show differential subunit each inhibitors. Addition strongly inhibited all activities, with completely CT-L PGPH MG-132 resulted weak activities. Multiple cells were more sensitive to induction apoptosis than BzLLLCOCHO. This study emphasizes need further investigation effects these compounds on gene expression allow development targeted

参考文章(26)
Mikael Altun, Paul J. Galardy, Reshma Shringarpure, Teru Hideshima, Richard LeBlanc, Kenneth C. Anderson, Hidde L. Ploegh, Benedikt M. Kessler, Effects of PS-341 on the Activity and Composition of Proteasomes in Multiple Myeloma Cells Cancer Research. ,vol. 65, pp. 7896- 7901 ,(2005) , 10.1158/0008-5472.CAN-05-0506
Teru Hideshima, Klaus Podar, Reshma Shringarpure, Dharminder Chauhan, Kenneth C Anderson, Guilan Li, Yasuyuki Ohtake, Blockade of Hsp27 Overcomes Bortezomib/Proteasome Inhibitor PS-341 Resistance in Lymphoma Cells Cancer Research. ,vol. 63, pp. 6174- 6177 ,(2003)
Eric S Lightcap, Teresa A McCormack, Christine S Pien, Vincent Chau, Julian Adams, Peter J Elliott, Proteasome Inhibition Measurements: Clinical Application Clinical Chemistry. ,vol. 46, pp. 673- 683 ,(2000) , 10.1093/CLINCHEM/46.5.673
M. Groll, W. Heinemeyer, S. Jager, T. Ullrich, M. Bochtler, D. H. Wolf, R. Huber, The catalytic sites of 20S proteasomes and their role in subunit maturation: A mutational and crystallographic study Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 10976- 10983 ,(1999) , 10.1073/PNAS.96.20.10976
Teru Hideshima, Kenneth C. Anderson, Molecular mechanisms of novel therapeutic approaches for multiple myeloma Nature Reviews Cancer. ,vol. 2, pp. 927- 937 ,(2002) , 10.1038/NRC952
Jayhyuk Myung, Kyung Bo Kim, Craig M. Crews, The Ubiquitin-Proteasome Pathway and Proteasome Inhibitors Medicinal Research Reviews. ,vol. 21, pp. 245- 273 ,(2001) , 10.1002/MED.1009
Dharminder Chauhan, Laurence Catley, Guilan Li, Klaus Podar, Teru Hideshima, Mugdha Velankar, Constantine Mitsiades, Nicolas Mitsiades, Hiroshi Yasui, Anthony Letai, Huib Ovaa, Celia Berkers, Benjamin Nicholson, Ta-Hsiang Chao, Saskia T.C. Neuteboom, Paul Richardson, Michael A. Palladino, Kenneth C. Anderson, A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib Cancer Cell. ,vol. 8, pp. 407- 419 ,(2005) , 10.1016/J.CCR.2005.10.013
Michele Pagano, Ramla Benmaamar, When protein destruction runs amok, malignancy is on the loose Cancer Cell. ,vol. 4, pp. 251- 256 ,(2003) , 10.1016/S1535-6108(03)00243-5
Alexei F Kisselev, Tatos N Akopian, Vanesa Castillo, Alfred L Goldberg, Proteasome Active Sites Allosterically Regulate Each Other, Suggesting a Cyclical Bite-Chew Mechanism for Protein Breakdown Molecular Cell. ,vol. 4, pp. 395- 402 ,(1999) , 10.1016/S1097-2765(00)80341-X
Sibylle Jäger, Michael Groll, Robert Huber, Dieter H Wolf, Wolfgang Heinemeyer, Proteasome beta-type subunits: unequal roles of propeptides in core particle maturation and a hierarchy of active site function. Journal of Molecular Biology. ,vol. 291, pp. 997- 1013 ,(1999) , 10.1006/JMBI.1999.2995